124 related articles for article (PubMed ID: 12214155)
1. Platelets and anticoagulant capacity in patients with inflammatory bowel disease.
Larsen TB; Nielsen JN; Fredholm L; Lund ED; Brandslund I; Munkholm P; Hey H
Pathophysiol Haemost Thromb; 2002; 32(2):92-6. PubMed ID: 12214155
[TBL] [Abstract][Full Text] [Related]
2. Markers of inflammation, activation of blood platelets and coagulation disorders in inflammatory bowel diseases.
Matowicka-Karna J
Postepy Hig Med Dosw (Online); 2016 Apr; 70():305-12. PubMed ID: 27117106
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of altered coagulation and fibrinolysis as measures of disease activity in active inflammatory bowel disease: a gender-stratified, cohort analysis.
Shen J; Ran ZH; Zhang Y; Cai Q; Yin HM; Zhou XT; Xiao SD
Thromb Res; 2009 Feb; 123(4):604-11. PubMed ID: 18499234
[TBL] [Abstract][Full Text] [Related]
4. Coagulation and fibrinolysis in inflammatory bowel disease and in giant cell arteritis.
Vrij AA; Rijken J; van Wersch JW; Stockbrügger RW
Pathophysiol Haemost Thromb; 2003; 33(2):75-83. PubMed ID: 14624048
[TBL] [Abstract][Full Text] [Related]
5. Platelet count, platelet function, coagulation activity and fibrinolysis in the acute phase of inflammatory bowel disease.
van Wersch JW; Houben P; Rijken J
J Clin Chem Clin Biochem; 1990 Aug; 28(8):513-7. PubMed ID: 2258713
[TBL] [Abstract][Full Text] [Related]
6. Continuous active state of coagulation system in patients with nonthrombotic inflammatory bowel disease.
Alkim H; Ayaz S; Alkim C; Ulker A; Sahin B
Clin Appl Thromb Hemost; 2011; 17(6):600-4. PubMed ID: 21593018
[TBL] [Abstract][Full Text] [Related]
7. Multipotent role of platelets in inflammatory bowel diseases: a clinical approach.
Voudoukis E; Karmiris K; Koutroubakis IE
World J Gastroenterol; 2014 Mar; 20(12):3180-90. PubMed ID: 24696603
[TBL] [Abstract][Full Text] [Related]
8. Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease.
Bjerregaard LT; Nederby NJ; Fredholm L; Brandslund I; Munkholm P; Hey H
Scand J Gastroenterol; 2002 Jan; 37(1):62-7. PubMed ID: 11843038
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor exposing microparticles in inflammatory bowel disease.
Palkovits J; Novacek G; Kollars M; Hron G; Osterode W; Quehenberger P; Kyrle PA; Vogelsang H; Reinisch W; Papay P; Weltermann A
J Crohns Colitis; 2013 Apr; 7(3):222-9. PubMed ID: 22705067
[TBL] [Abstract][Full Text] [Related]
10. Hypercoagulability and Platelet Abnormalities in Inflammatory Bowel Disease.
Senchenkova E; Seifert H; Granger DN
Semin Thromb Hemost; 2015 Sep; 41(6):582-9. PubMed ID: 26270113
[TBL] [Abstract][Full Text] [Related]
11. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease.
Payzin B; Adakan FY; Yalçin HC; Cetinkaya GS; Berkmen S; Eraslan S; Unsal B
Turk J Gastroenterol; 2006 Sep; 17(3):183-90. PubMed ID: 16941251
[TBL] [Abstract][Full Text] [Related]
12. Association between thrombocytosis and iron deficiency anemia in inflammatory bowel disease.
Voudoukis E; Karmiris K; Oustamanolakis P; Theodoropoulou A; Sfiridaki A; Paspatis GA; Koutroubakis IE
Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1212-6. PubMed ID: 23839158
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory and anticoagulant properties of the protein C system in inflammatory bowel disease.
Owczarek D; Cibor D; Sałapa K; Cieśla A; Głowacki MK; Pocztar H; Mach TH
Pol Arch Med Wewn; 2012; 122(5):209-16. PubMed ID: 22538795
[TBL] [Abstract][Full Text] [Related]
14. Systemic thromboembolism in inflammatory bowel disease: mechanisms and clinical applications.
Twig G; Zandman-Goddard G; Szyper-Kravitz M; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1051():166-73. PubMed ID: 16126956
[TBL] [Abstract][Full Text] [Related]
15. [Idiopathic inflammatory bowel disease as a prothrombotic state].
Kamenář D; Špičák J
Vnitr Lek; 2016; 62(5):384-91. PubMed ID: 27319231
[TBL] [Abstract][Full Text] [Related]
16. Review article: platelets in inflammatory bowel disease--pathogenetic role and therapeutic implications.
Collins CE; Rampton DS
Aliment Pharmacol Ther; 1997 Apr; 11(2):237-47. PubMed ID: 9146760
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum thrombopoietin and interleukin-6 concentrations in thrombocytosis associated with inflammatory bowel disease.
Heits F; Stahl M; Ludwig D; Stange EF; Jelkmann W
J Interferon Cytokine Res; 1999 Jul; 19(7):757-60. PubMed ID: 10454346
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory bowel disease: epidemiology, pathology and risk factors for hypercoagulability.
Owczarek D; Cibor D; Głowacki MK; Rodacki T; Mach T
World J Gastroenterol; 2014 Jan; 20(1):53-63. PubMed ID: 24415858
[TBL] [Abstract][Full Text] [Related]
19. [Hematologic aspects of inflammatory bowel diseases].
Udvardy M; Altorjay I; Palatka K
Orv Hetil; 2001 Apr; 142(17):883-6. PubMed ID: 11373889
[TBL] [Abstract][Full Text] [Related]
20. Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease.
Fägerstam JP; Whiss PA; Ström M; Andersson RG
Inflamm Res; 2000 Sep; 49(9):466-72. PubMed ID: 11071121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
